Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01890174 · ClinicalTrials.gov registry record
Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation
A clinical trial of Dry AMD With Macular Drusen, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- 54
- Enrollment target
- 1
- Study location
NCT01890174 is a study of Dry AMD With Macular Drusen that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 54 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01890174, a study of Dry AMD With Macular Drusen, has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine the repeatability and reproducibility of the Cirrus HD-OCT measurements of drusen area and volume.
Conditions Studied
Study Locations (1)
California
- Northern California Retina Vitreous Associates - Mountain View
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01890174
The ClinicalTrials.gov registry entry for NCT01890174 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carl Zeiss Meditec, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dry AMD With Macular Drusen appearing as the primary indexed condition, and to 0 interventions.
NCT01890174 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01890174 about?
NCT01890174 is a clinical study titled "Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation". The objective of this study is to determine the repeatability and reproducibility of the Cirrus HD-OCT measurements of drusen area and volume.
What is the current status of trial NCT01890174?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2011-02. Estimated completion is 2011-06.
What conditions does trial NCT01890174 study?
This clinical trial studies the following conditions: Dry AMD With Macular Drusen.
Who is sponsoring clinical trial NCT01890174?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01890174 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.